Press Releases

Cleveland Diagnostics Opens New Facility Amid Growing Demand for IsoPSA® Test

Continued clinical validation and Quest Diagnostics agreement fuel patient need; Expanded space supports platform development & prostate cancer test processing

CD Formulation Expands Its Healthcare Product Development and OEM/ODM Services

Huateng Pharma Announced To Attend INTERPEHX Week Tokyo - in-PHARMA JAPAN In July 2023

Huateng Pharma is a leading and professional manufacturer which can provide pharmaceutical intermediates, PEG derivatives, biochemical reagents, APIs, Vitamin D Derivatives and so on. We have a 34,000 square meter manufacturing site with advanced design concept of intelligent manufacturing, which can realize the integration of the production process and accomplish the complete transformation of lab scale - pilot plant - large-scale commercial production, with an annual capacity of more than 1 billion RMB.

Yourgene Health Presents Data Demonstrating Successful Fetal Fraction Enrichment in NIPT Workflows Following Prolonged Blood Storage in EDTA Tubes

Yourgene Health demonstrates prolonged storage of blood in EDTA tubes is compatible with NIPT when using size selection to enrich fetal fraction.

Amerigo Scientific Launches Ultra Low Temperature Freezers (-40°C to -86°C) for Lab Sample Storage

Amerigo Scientific launches its ultra-low temperature freezers with a temperature range from -40°C to -86°C.

Alfa Chemistry Commenced Offering Nonlinear Crystals and Precision Optical Materials

Mindpeak and Proscia Partner to Improve Cancer Diagnosis with Integrated AI-Powered Pathology Workflows

Collaboration marks step forward in realizing the promise of precision medicine

AntlerA Norrin/Wnt-agonist ANT antibody enters clinical trials through a strategic partnership with EyeBio

AntlerA Therapeutics has announced a strategic collaboration and licensing agreement with EyeBio to begin clinical testing of AntlerA's Norrin/Wnt-agonist, a treatment of leaky blood vessels in the eye.

Packaging Solutions Ensuring Product Integrity: Glass and Plastic Varieties

Creative Proteomics Expands Proteomics Services with Launch of N-Terminal Edman Degradation Service

Creative Proteomics Launches Crotonylation Proteomics Analysis Service to Enhance Your Epigenetic Research

Creative Proteomics Revolutionizes DNA-Protein Interaction Studies with Cutting-Edge DNA Pull Down Service

Creative Biolabs' Exhibition at BIO 2023 Accomplished

Creative Biolabs released exhibition highlight moments from their booth 2548 at the 2023 BIO International Convention held from June 5 to 8.

Alfa Chemistry: Test Kits Provides New Options to Transform Testing Strategy

Flexicon’s integrated solution for Müggenburg Pharma's filling line increases capacity for high-value product

PrecisionLife Announces Strategic CNS Drug Development Collaboration with Nanopharmaceutics

PrecisionLife and Nanopharmaceutics, Inc. has announced today a strategic collaboration aiming to accelerate and de-risk the development of Nanopharmaceutics’ portfolio of central nervous system assets.

SMi discloses £6 million seed funding round, bolsters team with new C-suite hire

SMi Systems has disclosed a £6m seed funding round to develop and prove the utility of a novel multi-omic platform for in vitro diagnosis and biomedical research.

New streamlined Alfa Laval Unique Mixproof CIP and Process valves meet market demand

The article announced the launch of two hygienic valves, Unique Mixproof CIP and Unique Mixproof Process. These valves allow simultaneous routing of different fluids, simplify maintenance, and reduce water and CIP media usage. Link: https://ins-news.com/en/100/81/2982/New-streamlined-Alfa-Laval-Unique-Mixproof-CIP-and-Process-valves-meet-market-demand.htm

CD ComputaBio Introduces First Principle Calculations for Revolutionizing Computational Chemistry and Empowering Biotech Research

BioIVT to Highlight its Expanded ADME-Tox Products and Services Portfolio at the European ISSX and DMDG Meeting

Dr. Joanna Barbara, Site Lead at BioIVT’s laboratory in Kansas City, will also present case studies that demonstrate how to account for complications like protein binding and drug instability in drug transporter studies.